MG
MilWealth Group Portfolio holdings
AUM
$388M
This Quarter Return
-1.21%
1 Year Return
+9.68%
3 Year Return
+29.42%
5 Year Return
+36.27%
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
(+13%)
Cap. Flow
+$32.7M
Cap. Flow
% of AUM
12.58%
Top 10 Holdings %
Top 10 Hldgs %
93.68%
Holding
176
New
117
Increased
18
Reduced
5
Closed
1
Top Buys
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$7.26M |
| 2 |
Vanguard Large-Cap ETF
VV
|
$4.2M |
| 3 |
Dimensional World ex US Core Equity 2 ETF
DFAX
|
$3.67M |
| 4 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
$3.39M |
| 5 |
Vanguard Small-Cap ETF
VB
|
$3.26M |
Top Sells
| 1 |
KeyCorp
KEY
|
$174K |
| 2 |
Vanguard Value ETF
VTV
|
$47.4K |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
$27.1K |
| 4 |
US Bancorp
USB
|
$16.1K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$4.96K |
Sector Composition
| 1 | Technology | 0.29% |
| 2 | Financials | 0.18% |
| 3 | Industrials | 0.11% |
| 4 | Consumer Staples | 0.1% |
| 5 | Healthcare | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Marsh & McLennan
MMC
$101B
| $2.42K | ﹤0.01% |
+16
| New | +$2.42K |
|
127
Waste Management
WM
$90.8B
| $2.39K | ﹤0.01% |
+16
| New | +$2.39K |
|
128
Amdocs
DOX
$9.28B
| $2.35K | ﹤0.01% |
+31
| New | +$2.35K |
|
129
UnitedHealth
UNH
$280B
| $2.35K | ﹤0.01% |
+6
| New | +$2.35K |
|
130
JB Hunt Transport Services
JBHT
$13.9B
| $2.34K | ﹤0.01% |
+14
| New | +$2.34K |
|
131
Zoetis
ZTS
$67.6B
| $2.33K | ﹤0.01% |
+12
| New | +$2.33K |
|
132
Alexandria Real Estate Equities
ARE
$13.8B
| $2.29K | ﹤0.01% |
+12
| New | +$2.29K |
|
133
Dayforce
DAY
$11B
| $2.25K | ﹤0.01% |
+20
| New | +$2.25K |
|
134
GoDaddy
GDDY
$20B
| $2.23K | ﹤0.01% |
+32
| New | +$2.23K |
|
135
Masimo
MASI
$7.48B
| $2.17K | ﹤0.01% |
+8
| New | +$2.17K |
|
136
Honda
HMC
$44.8B
| $2.15K | ﹤0.01% |
+70
| New | +$2.15K |
|
137
Alliant Energy
LNT
$16.6B
| $2.13K | ﹤0.01% |
+38
| New | +$2.13K |
|
138
Valero Energy
VLO
$47.9B
| $2.12K | ﹤0.01% |
+30
| New | +$2.12K |
|
139
Boston Scientific
BSX
$158B
| $2.08K | ﹤0.01% |
+48
| New | +$2.08K |
|
140
Barclays
BCS
$68.6B
| $2.02K | ﹤0.01% |
+196
| New | +$2.02K |
|
141
W.R. Berkley
WRB
$27.3B
| $1.98K | ﹤0.01% |
+27
| New | +$1.98K |
|
142
Dollar General
DG
$24.3B
| $1.91K | ﹤0.01% |
+9
| New | +$1.91K |
|
143
Cintas
CTAS
$82.9B
| $1.9K | ﹤0.01% |
+5
| New | +$1.9K |
|
144
Best Buy
BBY
$15.7B
| $1.8K | ﹤0.01% |
+17
| New | +$1.8K |
|
145
Nektar Therapeutics
NKTR
$555M
| $1.78K | ﹤0.01% |
99
| – | – |
|
146
POSCO
PKX
$15.2B
| $1.66K | ﹤0.01% |
+24
| New | +$1.66K |
|
147
Eli Lilly
LLY
$659B
| $1.62K | ﹤0.01% |
+7
| New | +$1.62K |
|
148
Charles Schwab
SCHW
$174B
| $1.6K | ﹤0.01% |
+22
| New | +$1.6K |
|
149
Accenture
ACN
$159B
| $1.6K | ﹤0.01% |
+5
| New | +$1.6K |
|
150
Crown Castle
CCI
$42.6B
| $1.56K | ﹤0.01% |
+9
| New | +$1.56K |
|